相关实验视频
Updated: Jun 17, 2026

08:49
External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
15.9K
临床特征与非常早产,尽管 Transabdominal Cerclage 相关的临床特征:一个队列研究
Laura van der Krogt1, Lisa Story1, Natalie Suff1
1Division of Women's Health, King's College London, St Thomas' Hospital, London, UK.
BJOG : an international journal of obstetrics and gynaecology
|February 16, 2026
概括
跨腹腔围 (TAC) 对于预防早产非常有效,超过90%的妇女在32周后分娩. 不成功的TAC结果与之前的气管切除术和短的宫长度有关.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 对于早产的外科干预.
背景情况:
- 腹腔外围护理 (TAC) 是一种用于预防宫衰竭妇女早产的外科手术.
- 识别与TAC失败相关的因素对于优化TAC使用和改善妊娠结果至关重要.
研究的目的:
- 为了确定与不成功的跨腹部带 (TAC) 插入相关的因素,定义为在32周前分娩.
- 评估母亲人口结构的影响,早产风险因素,以及 TAC 成功的操作细节.
主要方法:
- 在伦敦一家三级医院进行了观察性队列研究.
- 分析了从2011年至2024年期间接受TAC的125个怀孕的数据.
- 使用统计比较 (t-test,chi-squared) 来确定重要因素.
主要成果:
- 根据TAC,只有6.4%的怀孕在32周前分娩.
- 以前的气管切除术与早产严重相关 (p < 0.0001).
- 在早孕期间,与晚产者相比,早产妇的子宫长度显著缩短.
结论:
- 跨腹腔围 (TAC) 显示出高效率,超过90%的妇女在32周后分娩.
- 之前的气管切除术和怀孕早期的宫长短是与未成功的TAC相关的关键因素.
- 在随后的怀孕中,TAC的有效性是持续的,许多妇女在相同的 cerclage 中实现了多次分娩.
相关概念视频
Case Studies
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...

